Company intelligence / Profile preview
MGC Pharmaceuticals
United Kingdommgcpharma.co.uk ↗
- Ownership
- Private
- Employees
- ~41
- Development stage
- Other
01
Overview
MGC Pharmaceuticals has developed a portfolio of plant-inspired medicines with three flagship products—CannEpil®, CimetrA®, CogniCann®—in late-stage clinical development. CannEpil® is used for refractory epilepsy/cerebral palsy; CimetrA® for acute lung injury/COVID symptoms; CogniCann® for dementia/Alzheimer's. The company leverages real-world data from early access programs to support regulatory filings. Additional pipeline assets target oncology (glioblastoma) and autoimmune/inflammatory diseases.
- Therapeutic areas
- GastroenterologyPulmonologyImmunologyOncologyNeurologyInfectious Diseases
- Modalities
- Small moleculePlant-derived medicineNutraceutical
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
AMC in the US market for distribution of plant-based productsacademic institutions in Europe and Israel
Beyond the preview
Go deeper on MGC Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MGC Pharmaceuticals.